Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Kloor

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
The Lancet. Oncology|September 1, 2009
Lymphocyte infiltration and prognosis in colorectal cancerMatthias Kloor
Annals of Translational Medicine|February 13, 2020
Resistance of the stable-towards more precise prediction of response to immune checkpoint blockade in microsatellite-unstable cancer patientsMatthias Kloor
The New England Journal of Medicine|September 25, 2024
Reactivation of SOX17 Program as Immune-Evasion Mechanism in Early Colorectal Cancer DevelopmentAysel Ahadova, Matthias Kloor
Trends in Cancer|July 26, 2017
The Immune Biology of Microsatellite-Unstable CancerMatthias Kloor, Magnus von Knebel Doeberitz
Familial Cancer|June 14, 2013
Towards a vaccine to prevent cancer in Lynch syndrome patientsMagnus von Knebel Doeberitz, Matthias Kloor
Oncoimmunology|March 28, 2017
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevanceBarbara Seliger, Matthias Kloor, Soldano Ferrone
Lancet (London, England)|November 15, 2013
Colorectal cancerHermann Brenner, Matthias Kloor, Christian Peter Pox
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2011
Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMPArne Warth, Matthias Kloor, Peter Schirmacher, et al.
International Journal of Cancer|March 4, 2010
Immune evasion of microsatellite unstable colorectal cancersMatthias Kloor, Sara Michel, Magnus von Knebel Doeberitz
Expert Review of Molecular Diagnostics|July 15, 2005
Molecular testing for microsatellite instability and its value in tumor characterizationMatthias Kloor, Magnus von Knebel Doeberitz, Johannes F Gebert
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
The Lancet. Oncology|September 1, 2009
Lymphocyte infiltration and prognosis in colorectal cancerMatthias Kloor
Annals of Translational Medicine|February 13, 2020
Resistance of the stable-towards more precise prediction of response to immune checkpoint blockade in microsatellite-unstable cancer patientsMatthias Kloor
The New England Journal of Medicine|September 25, 2024
Reactivation of SOX17 Program as Immune-Evasion Mechanism in Early Colorectal Cancer DevelopmentAysel Ahadova, Matthias Kloor
Trends in Cancer|July 26, 2017
The Immune Biology of Microsatellite-Unstable CancerMatthias Kloor, Magnus von Knebel Doeberitz
Familial Cancer|June 14, 2013
Towards a vaccine to prevent cancer in Lynch syndrome patientsMagnus von Knebel Doeberitz, Matthias Kloor
Oncoimmunology|March 28, 2017
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevanceBarbara Seliger, Matthias Kloor, Soldano Ferrone
Lancet (London, England)|November 15, 2013
Colorectal cancerHermann Brenner, Matthias Kloor, Christian Peter Pox
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2011
Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMPArne Warth, Matthias Kloor, Peter Schirmacher, et al.
International Journal of Cancer|March 4, 2010
Immune evasion of microsatellite unstable colorectal cancersMatthias Kloor, Sara Michel, Magnus von Knebel Doeberitz
Expert Review of Molecular Diagnostics|July 15, 2005
Molecular testing for microsatellite instability and its value in tumor characterizationMatthias Kloor, Magnus von Knebel Doeberitz, Johannes F Gebert
Pageof 21